Medicines Evaluation Board | College ter Beoordeling van Geneesmiddelen

Go back

Everyone who uses a medicine must be able to rely on it. That is what the MEB is working on, for the Netherlands as well as for Europe.

As the official (and only) Dutch organization granting market access, we assess the efficacy and safety of drugs to determine whether they will be approved. We also continuously monitor all risks and side effects of a drug after it has been admitted to the market. Assessing a drug is not a matter of ticking off a checklist. It is a complex balancing of benefits and risks, based on scientific analysis of data. During the assessment, the patient’s well-being is always at the center of attention. We handle some 20,000 dossiers a year, from simple changes to complex dossiers involving new substances. Trust in medicines is high in the Netherlands, we are proud of that and we want to keep it that way!

What kind of jobs or internships are available in your company?

clinical assessor, chemical-pharmaceutical assessor, regulatory project leader, assessor biotechnology, methodologist, regulatory project officer, assessor veterinary drugs.